{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:22:59Z","timestamp":1793830979698,"version":"4.6.1"},"reference-count":176,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.critrevonc.2009.04.003","type":"journal-article","created":{"date-parts":[[2009,5,8]],"date-time":"2009-05-08T05:10:13Z","timestamp":1241759413000},"page":"141-155","source":"Crossref","is-referenced-by-count":144,"title":["Male breast cancer"],"prefix":"10.1016","volume":"73","author":[{"given":"Laura","family":"Ottini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Palli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Bazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2009.04.003_bib1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(06)68226-3","article-title":"Male breast cancer","volume":"367","author":"Fentiman","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/1055-9965.20.14.1","article-title":"Epidemiology of male breast cancer","volume":"14","author":"Weiss","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib3","doi-asserted-by":"crossref","first-page":"678","DOI":"10.7326\/0003-4819-137-8-200210150-00013","article-title":"Breast cancer in men","volume":"137","author":"Giordano","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib4","first-page":"176","article-title":"Carcinoma of the male breast in Zambia","volume":"49","author":"Bhagwandin","year":"1972","journal-title":"East Afr Med J"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib5","first-page":"489","article-title":"Carcinoma of the male breast in Mulago Hospital, Kampala","volume":"55","author":"Ojara","year":"1978","journal-title":"East Afr Med J"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib6","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ijc.2910530403","article-title":"Review article: epidemiology of male breast cancer. A meta-analysis of published case\u2013control studies and discussion of selected aetiological factors","volume":"53","author":"Sasco","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib7","unstructured":"Cancer incidence in five continents. IARC Sci Publ 1976; 1\u2013583."},{"key":"10.1016\/j.critrevonc.2009.04.003_bib8","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-007-9882-3","article-title":"Decline in breast cancer incidence in the United States: what about male breast cancer?","author":"Stang","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib9","first-page":"406","article-title":"The \u2018other half\u2019 of breast cancer: a review of male breast cancer","volume":"2","author":"Ying","year":"2005","journal-title":"J Men's Health"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib10","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/cncr.10521","article-title":"Racial\/ethnic differences in survival rates in a population-based series of men with breast carcinoma","volume":"94","author":"O\u2019Malley","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cncr.20312","article-title":"Breast carcinoma in men: a population-based study","volume":"101","author":"Giordano","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib12","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1634\/theoncologist.10-7-471","article-title":"A review of the diagnosis and management of male breast cancer","volume":"10","author":"Giordano","year":"2005","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib13","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.ejca.2004.07.012","article-title":"A gene-environment interaction between occupation and BRCA1\/BRCA2 mutations in male breast cancer?","volume":"40","author":"Palli","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib14","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/oxfordjournals.aje.a116360","article-title":"Breast cancer in men: risk factors with hormonal implications","volume":"135","author":"Thomas","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1572-0241.1998.00231.x","article-title":"Risk of breast cancer in men with liver cirrhosis","volume":"93","author":"Sorensen","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib16","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/bjc.1995.264","article-title":"Risk factors for male breast cancer","volume":"71","author":"D\u2019Avanzo","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/028418601750288181","article-title":"Risk factors for male breast cancer\u2014a case\u2013control study from Scandinavia","volume":"40","author":"Ewertz","year":"2001","journal-title":"Acta Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00008469-200206000-00009","article-title":"Risk factors for male breast cancer in Canada, 1994\u20131998","volume":"11","author":"Johnson","year":"2002","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00008469-200504000-00016","article-title":"The intrauterine origin of male breast cancer: a birth order study in Denmark","volume":"14","author":"Sorensen","year":"2005","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib20","first-page":"4293","article-title":"Prevalence of Klinefelter's syndrome in male breast cancer patients","volume":"17","author":"Hultborn","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1439-0272.2004.00639.x","article-title":"Male breast cancer\u2014an andrological disease: risk factors and diagnosis","volume":"36","author":"Krause","year":"2004","journal-title":"Andrologia"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/01.SMJ.0000050686.54786.79","article-title":"Bilateral synchronous carcinoma of the male breast in a patient receiving estrogen therapy for carcinoma of the prostate: cause or coincidence?","volume":"97","author":"Coard","year":"2004","journal-title":"South Med J"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/bjs.1800820319","article-title":"Breast cancer in a trans-sexual man receiving hormone replacement therapy","volume":"82","author":"Ganly","year":"1995","journal-title":"Br J Surg"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib24","first-page":"1077","article-title":"Male breast adenocarcinoma in a prostate cancer patient following prolonged anti-androgen monotherapy","volume":"24","author":"Karamanakos","year":"2004","journal-title":"Anticancer Res"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF01830721","article-title":"Ionizing radiation and breast cancer in men (United States)","volume":"5","author":"Thomas","year":"1994","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib26","first-page":"371","article-title":"Risk factors for male breast cancer","volume":"74","author":"Mabuchi","year":"1985","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib27","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/1097-0274(200103)39:3<276::AID-AJIM1015>3.0.CO;2-B","article-title":"Breast cancer, occupation, and exposure to electromagnetic fields among Swedish men","volume":"39","author":"Pollan","year":"2001","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib28","first-page":"758","article-title":"Incidence of cancer in persons with occupational exposure to electromagnetic fields in Denmark","volume":"50","author":"Guenel","year":"1993","journal-title":"Br J Ind Med"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib29","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1186\/bcr419","article-title":"BRCA1 and BRCA2 mutations in a population-based study of male breast cancer","volume":"4","author":"Basham","year":"2002","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib30","first-page":"342","article-title":"BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy","volume":"63","author":"Ottini","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2407-7-170","article-title":"Association between the BRCA2 N372H variant and male breast cancer risk: a population-based case\u2013control study in Tuscany, Central Italy","volume":"7","author":"Palli","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib32","first-page":"1326","article-title":"A case\u2013control study of male breast cancer","volume":"48","author":"Casagrande","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib33","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ijc.2910450415","article-title":"Risk factors for male breast cancer: a Franco-Swiss case\u2013control study","volume":"45","author":"Lenfant-Pejovic","year":"1990","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib34","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jnci\/83.12.849","article-title":"Breast cancer in men: aspects of familial aggregation","volume":"83","author":"Rosenblatt","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/A:1006030116357","article-title":"Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome","volume":"53","author":"Boyd","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/jmg.38.3.159","article-title":"Male breast cancer in Cowden syndrome patients with germline PTEN mutations","volume":"38","author":"Fackenthal","year":"2001","journal-title":"J Med Genet"},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2009.04.003_bib37","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1186\/bcr1643","article-title":"Risk of second primary cancer in men with breast cancer","volume":"9","author":"Satram-Hoang","year":"2007","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib38","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/jnci\/94.17.1330","article-title":"Risk of subsequent cancer following breast cancer in men","volume":"94","author":"Auvinen","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib39","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1200\/JCO.1995.13.7.1578","article-title":"Contralateral breast cancer: annual incidence and risk parameters","volume":"13","author":"Broet","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib40","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.bjc.6602505","article-title":"Second primary malignancies in patients with male breast cancer","volume":"92","author":"Hemminki","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib41","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib42","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.20.6.1480","article-title":"Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals","volume":"20","author":"Frank","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/humu.10154","article-title":"Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2","volume":"20","author":"Liede","year":"2002","journal-title":"Hum Mutat"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib44","first-page":"1079","article-title":"Study of a single BRCA2 mutation with high carrier frequency in a small population","volume":"60","author":"Thorlacius","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib45","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejmg.2007.11.001","article-title":"Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976\u20131999","volume":"51","author":"Chodick","year":"2008","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/humu.1167","article-title":"Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast\/ovarian cancer","volume":"18","author":"Baudi","year":"2001","journal-title":"Hum Mutat"},{"issue":"Suppl 6","key":"10.1016\/j.critrevonc.2009.04.003_bib47","doi-asserted-by":"crossref","first-page":"vi93","DOI":"10.1093\/annonc\/mdm234","article-title":"Founder mutations in BRCA1 and BRCA2 genes","volume":"18","author":"Ferla","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1200\/JCO.2007.13.2118","article-title":"BRCA1 p. Val1688del is a deleterious mutation that recurs in breast and ovarian cancer families from Northeast Italy","volume":"26","author":"Malacrida","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib49","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1054\/bjoc.1999.0963","article-title":"Identification of a founder BRCA2 mutation in Sardinia","volume":"82","author":"Pisano","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib50","article-title":"Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?","author":"Russo","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10689-007-9153-9","article-title":"BRCA1\/2 mutation analysis in male breast cancer families from North West England","volume":"7","author":"Evans","year":"2008","journal-title":"Fam Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib52","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1471-2407-6-156","article-title":"Phenotypic features and genetic characterization of male breast cancer families: identification of two recurrent BRCA2 mutations in north-east of Italy","volume":"6","author":"Miolo","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib53","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng879","article-title":"Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations","volume":"31","author":"Meijers-Heijboer","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib54","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10549-007-9689-2","article-title":"BRCA1\/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases","volume":"110","author":"Falchetti","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib55","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ijc.11385","article-title":"Role of CHEK2*1100delC in unselected series of non-BRCA1\/2 male breast cancers","volume":"108","author":"Neuhausen","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib56","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/ijc.11603","article-title":"CHEK2*1100delC and male breast cancer risk in Israel","volume":"108","author":"Ohayon","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib57","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ijc.11384","article-title":"CHEK2 1100delC is not a risk factor for male breast cancer population","volume":"108","author":"Syrjakoski","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10549-006-9351-4","article-title":"CHEK2 1100delC is present in familial breast cancer cases of the Basque Country","volume":"103","author":"Martinez-Bouzas","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib59","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ng1092-132","article-title":"A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome","volume":"2","author":"Wooster","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib60","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/A:1021369508561","article-title":"Androgen receptor gene alterations in Finnish male breast cancer","volume":"77","author":"Syrjakoski","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib61","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.bjc.6690663","article-title":"A polymorphism in the CYP17 gene is associated with male breast cancer","volume":"81","author":"Young","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib62","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/318181","article-title":"Variation in cancer risks, by mutation position, in BRCA2 mutation carriers","volume":"68","author":"Thompson","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib63","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","article-title":"Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program","volume":"94","author":"Brose","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib64","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/jnci\/djm203","article-title":"Breast cancer risk among male BRCA1 and BRCA2 mutation carriers","volume":"99","author":"Tai","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib65","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium","volume":"91","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib66","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1200\/JCO.2004.05.055","article-title":"Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature","volume":"22","author":"Liede","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib67","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","article-title":"Cancer Incidence in BRCA1 mutation carriers","volume":"94","author":"Thompson","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib68","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1086\/316907","article-title":"Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling","volume":"67","author":"Liede","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib69","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/1097-0142(19860315)57:6<1181::AID-CNCR2820570619>3.0.CO;2-T","article-title":"Lobular carcinoma of the breast in a patient with Klinefelter's syndrome. A case with bilateral, synchronous, histologically different breast tumors","volume":"57","author":"Sanchez","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib70","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF00053155","article-title":"Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men","volume":"4","author":"Stalsberg","year":"1993","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib71","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/cncr.21353","article-title":"In situ male breast carcinoma in the surveillance, epidemiology, and end results database of the National Cancer Institute","volume":"104","author":"Anderson","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib72","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/1097-0142(197310)32:4<985::AID-CNCR2820320433>3.0.CO;2-0","article-title":"Male breast cancer. I. Histologic typing and grading of 187 Danish cases","volume":"32","author":"Visfeldt","year":"1973","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib73","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/B:BREA.0000010701.08825.2d","article-title":"Is male breast cancer similar or different than female breast cancer?","volume":"83","author":"Anderson","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib74","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/0959-8049(95)00366-5","article-title":"Male breast cancer: results of the treatments and prognostic factors in 397 cases","volume":"31A","author":"Cutuli","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib75","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/(SICI)1097-0142(19990201)85:3<629::AID-CNCR13>3.0.CO;2-V","article-title":"Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955\u20131996","volume":"85","author":"Goss","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib76","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.annepidem.2005.01.001","article-title":"Comparison of male and female breast cancer incidence trends, tumor characteristics, and survival","volume":"15","author":"Hill","year":"2005","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib77","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0960-9776(96)90058-2","article-title":"A review of the management of the male breast carcinoma based on an analysis of 420 treated cases","volume":"5","author":"Ribeiro","year":"1996","journal-title":"Breast"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib78","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1023\/A:1012221921416","article-title":"Clinical relevance of biologic factors in male breast cancer","volume":"68","author":"Meijer-van Gelder","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib79","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0960-0760(98)00124-1","article-title":"Proliferative activity and steroid hormone receptor status in male breast carcinoma","volume":"67","author":"Munoz de Toro","year":"1998","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib80","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0002-9610(01)00733-4","article-title":"Status of HER-2 in male and female breast carcinoma","volume":"182","author":"Bloom","year":"2001","journal-title":"Am J Surg"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib81","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5858\/2003-127-36-MVFB","article-title":"Male versus female breast cancers. A population-based comparative immunohistochemical analysis","volume":"127","author":"Muir","year":"2003","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib82","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1159\/000227220","article-title":"Expression of the c-erbB2 proto-oncogene in male breast carcinoma: lack of prognostic significance","volume":"50","author":"Blin","year":"1993","journal-title":"Oncology"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib83","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/jcp.45.10.942-c","article-title":"c-erb-B-2 expression in male breast carcinoma","volume":"45","author":"Leach","year":"1992","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib84","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/B:BREA.0000019953.92921.7e","article-title":"Her-2\/neu gene amplification and protein expression in primary male breast cancer","volume":"84","author":"Rudlowski","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib85","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/annonc\/mdf252","article-title":"Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites","volume":"13","author":"Gancberg","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib86","article-title":"BRCA1\/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy","author":"Ottini","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib87","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/1097-0142(197908)44:2<748::AID-CNCR2820440248>3.0.CO;2-9","article-title":"Male breast cancer: a natural history study","volume":"44","author":"Yap","year":"1979","journal-title":"Cancer"},{"issue":"Suppl","key":"10.1016\/j.critrevonc.2009.04.003_bib88","first-page":"3","article-title":"Male breast cancer","volume":"251","author":"Scheike","year":"1975","journal-title":"Acta Pathol Microbiol Scand Suppl"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib89","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/BF00295904","article-title":"Male breast cancer: Austrian experience","volume":"19","author":"Stierer","year":"1995","journal-title":"World J Surg"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib90","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/1097-0142(1955)8:6<1239::AID-CNCR2820080622>3.0.CO;2-E","article-title":"Cancer of the male breast; a report of 146 cases","volume":"8","author":"Treves","year":"1955","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib91","first-page":"149","article-title":"Male breast cancer","volume":"7","author":"Carlsson","year":"1981","journal-title":"Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib92","first-page":"281","article-title":"Male breast cancer: about 123 cases collected at the Institute Salah-Azaiz of Tunis from 1979 to 1999","volume":"92","author":"Ben Dhiab","year":"2005","journal-title":"Bull Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib93","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1148\/rg.264055116","article-title":"Imaging characteristics of malignant lesions of the male breast","volume":"26","author":"Chen","year":"2006","journal-title":"Radiographics"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib94","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0002-9610(00)00571-7","article-title":"The diagnostic accuracy of mammography in the evaluation of male breast disease","volume":"181","author":"Evans","year":"2001","journal-title":"Am J Surg"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib95","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1075-122X.2006.00298.x","article-title":"Outcome of men presenting with clinical breast problems: the role of mammography and ultrasound","volume":"12","author":"Patterson","year":"2006","journal-title":"Breast J"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib96","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<498::AID-CNCR19>3.0.CO;2-R","article-title":"Carcinoma of the breast in males: a multiinstitutional survey","volume":"83","author":"Donegan","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib97","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0002-9610(97)89592-X","article-title":"A comparison outcome of male breast cancer with female breast cancer","volume":"173","author":"Willsher","year":"1997","journal-title":"Am J Surg"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib98","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/1097-0142(19930101)71:1<154::AID-CNCR2820710125>3.0.CO;2-#","article-title":"The prognosis of breast cancer in males. A report of 335 cases","volume":"71","author":"Guinee","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib99","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1517\/14656566.8.2.193","article-title":"Strategies in treating male breast cancer","volume":"8","author":"Cutuli","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib100","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/(SICI)1097-0142(19960201)77:3<490::AID-CNCR10>3.0.CO;2-#","article-title":"Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome","volume":"77","author":"Joshi","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib101","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00000658-199205000-00007","article-title":"Current management of male breast cancer. A review of 104 cases","volume":"215","author":"Borgen","year":"1992","journal-title":"Ann Surg"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib102","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00000658-197807000-00010","article-title":"Male breast cancer: a clinicopathologic study of 97 cases","volume":"188","author":"Heller","year":"1978","journal-title":"Ann Surg"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib103","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0960-7404(93)90063-5","article-title":"A 50-year experience of male breast cancer: is outcome changing?","volume":"2","author":"Gough","year":"1993","journal-title":"Surg Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib104","first-page":"373","article-title":"Prognostic factors of carcinoma of the male breast","volume":"159","author":"Ouriel","year":"1984","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib105","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/1097-0142(19850201)55:3<648::AID-CNCR2820550329>3.0.CO;2-3","article-title":"Long-term survival following cancer of the male breast in Northern Ireland. A report of 81 cases","volume":"55","author":"Spence","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib106","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.1996.14.5.1558","article-title":"Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group","volume":"14","author":"Arriagada","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib107","first-page":"19","article-title":"Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group","author":"Blichert-Toft","year":"1992","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib108","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199511303332203","article-title":"Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer","volume":"333","author":"Fisher","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib109","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0959-8049(05)80113-3","article-title":"Ductal carcinoma in-situ of the breast; second EORTC consensus meeting","volume":"28","author":"van Dongen","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/BF00348194","article-title":"Conservation approaches for the management of stage I\/II carcinoma of the breast: Milan Cancer Institute trials","volume":"18","author":"Veronesi","year":"1994","journal-title":"World J Surg"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib111","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.breast.2007.05.012","article-title":"Breast conservation for male breast carcinoma","volume":"16","author":"Golshan","year":"2007","journal-title":"Breast"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib112","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/cncr.22589","article-title":"Male breast cancer in the veterans affairs population: a comparative analysis","volume":"109","author":"Nahleh","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib113","first-page":"358","article-title":"Carcinoma of the male breast: reconstructive technique","volume":"19","author":"Caglia","year":"1998","journal-title":"G Chir"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib114","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/00006534-199810000-00043","article-title":"Breast reconstruction in a male with a transverse rectus abdominis flap","volume":"102","author":"Spear","year":"1998","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib115","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0011-3840(05)80015-2","article-title":"Axillary dissection: current practice and technique","volume":"32","author":"Petrek","year":"1995","journal-title":"Curr Probl Surg"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib116","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-005-9025-7","article-title":"Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer","volume":"95","author":"Fleissig","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib117","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJM199810013391401","article-title":"The sentinel node in breast cancer\u2014a multicenter validation study","volume":"339","author":"Krag","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib118","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/91.4.368","article-title":"Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series","volume":"91","author":"Veronesi","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib119","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1053\/ejso.1999.0674","article-title":"Sentinel node biopsy in male breast cancer","volume":"25","author":"Hill","year":"1999","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib120","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jamcollsurg.2006.06.014","article-title":"Comparative analysis of sentinel lymph node operation in male and female breast cancer patients","volume":"203","author":"Boughey","year":"2006","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib121","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/jso.20045","article-title":"Efficacy of sentinel lymph node biopsy in male breast cancer","volume":"86","author":"Cimmino","year":"2004","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib122","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jamcollsurg.2007.11.005","article-title":"Sentinel lymph node biopsy is successful and accurate in male breast carcinoma","volume":"206","author":"Flynn","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib123","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1634\/theoncologist.12-5-512","article-title":"Sentinel lymph node biopsy in male patients with early breast cancer","volume":"12","author":"Gentilini","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib124","first-page":"663","article-title":"Male breast cancer: a special therapeutic problem. Anything new? (Review)","volume":"24","author":"Gennari","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib125","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0039-6060(99)70135-2","article-title":"An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients","volume":"126","author":"Scott-Conner","year":"1999","journal-title":"Surgery"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib126","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0167-8140(02)00210-4","article-title":"Post-mastectomy radiation in male breast cancer","volume":"65","author":"Chakravarthy","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib127","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/annonc\/mdi274","article-title":"A comparative analysis of radiotherapy use and patient outcome in males and females with breast cancer","volume":"16","author":"Macdonald","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib128","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0167-8140(99)00122-X","article-title":"Adjuvant radiotherapy in male breast cancer","volume":"53","author":"Stranzl","year":"1999","journal-title":"Radiother Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2009.04.003_bib129","first-page":"S130","article-title":"Postoperative radiotherapy in male breast cancer","volume":"64","author":"Ober","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/030089160509100209","article-title":"External beam radiotherapy in the treatment of male breast carcinoma: patterns of failure in a single institute experience","volume":"91","author":"Zabel","year":"2005","journal-title":"Tumori"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib131","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/S0360-3016(98)80363-5","article-title":"Male breast cancer: results of the treatments and prognostic factors in 690 cases","volume":"42","author":"Cutuli","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib132","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10549-006-9356-z","article-title":"Male breast cancer: a review of clinical management","volume":"103","author":"Agrawal","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib133","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1477-7819-6-58","article-title":"Male breast cancer: is the scenario changing","volume":"6","author":"Contractor","year":"2008","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib134","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.breast.2007.07.024","article-title":"How to treat male breast cancer","volume":"16","author":"Kamila","year":"2007","journal-title":"Breast"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib135","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0360-3016(01)01465-1","article-title":"Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: implications for adjuvant irradiation","volume":"50","author":"Katz","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2009.04.003_bib136","first-page":"S121","article-title":"Male breast carcinoma: outcomes and predictors of locoregional failure in patients treated without radiation therapy","volume":"76","author":"Perkins","year":"2002","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib137","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0959-8049(96)00436-4","article-title":"Ductal carcinoma in situ of the male breast. Analysis of 31 cases","volume":"33","author":"Cutuli","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib138","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1200\/JCO.1984.2.8.903","article-title":"Male breast cancer: a 13-year review of 89 patients","volume":"2","author":"Erlichman","year":"1984","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib139","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1586\/14737140.6.2.205","article-title":"Optimizing locoregional control and survival for women with breast cancer: a review of current developments in postmastectomy radiotherapy","volume":"6","author":"Truong","year":"2006","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib140","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials","volume":"365","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib141","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/cncr.21526","article-title":"Adjuvant systemic therapy for male breast carcinoma","volume":"104","author":"Giordano","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib142","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3109\/02841869409083946","article-title":"Male breast cancer. Report of a series of 50 cases","volume":"33","author":"Izquierdo","year":"1994","journal-title":"Acta Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib143","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/1097-0142(19891015)64:8<1583::AID-CNCR2820640804>3.0.CO;2-Q","article-title":"Role of adjuvant chemotherapy in male breast cancer","volume":"64","author":"Patel","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib144","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0748-7983(98)93608-3","article-title":"Male breast cancer: a 22-year experience","volume":"24","author":"Yildirim","year":"1998","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00000421-198702000-00013","article-title":"Adjuvant chemotherapy in males with cancer of the breast","volume":"10","author":"Bagley","year":"1987","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib146","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/annonc\/mdm271","article-title":"Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007","volume":"18","author":"Goldhirsch","year":"2007","journal-title":"Ann Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2009.04.003_bib147","first-page":"S42","article-title":"Male breast cancer: the M.D. Anderson experience with adjuvant therapy","volume":"82","author":"Giordano","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib148","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/bjc.1992.50","article-title":"Adjuvant tamoxifen for male breast cancer (MBC)","volume":"65","author":"Ribeiro","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib149","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejca.2005.09.027","article-title":"The experiences of men with breast cancer in the United Kingdom","volume":"42","author":"Iredale","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/1097-0142(19940701)74:1<74::AID-CNCR2820740113>3.0.CO;2-#","article-title":"Tamoxifen administration is associated with a high rate of treatment-limiting symptoms in male breast cancer patients","volume":"74","author":"Anelli","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib151","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1210\/jc.85.7.2370","article-title":"Estrogen suppression in males: metabolic effects","volume":"85","author":"Mauras","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib152","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.revmed.2003.12.006","article-title":"[Complete remission obtained with letrozole in a man with metastatic breast cancer]","volume":"25","author":"Italiano","year":"2004","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib153","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/jso.20233","article-title":"Successful use of letrozole in male breast cancer: a case report and review of hormonal therapy for male breast cancer","volume":"90","author":"Zabolotny","year":"2005","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib154","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0039-6109(16)45237-0","article-title":"Male breast cancer","volume":"70","author":"Crichlow","year":"1990","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib155","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0039-6109(05)70443-6","article-title":"Breast cancer in men","volume":"76","author":"Donegan","year":"1996","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib156","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1126\/science.95.2478.654","article-title":"Effect of orchidectomy on skeletal metastases from cancer of the male breast","volume":"95","author":"Farrow","year":"1942","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib157","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000226061","article-title":"Hormonal treatment of disseminated male breast cancer","volume":"42","author":"Lopez","year":"1985","journal-title":"Oncology"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib158","first-page":"1882","article-title":"Tamoxifen before and after orchiectomy in advanced male breast cancer","volume":"66","author":"Tirelli","year":"1982","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib159","doi-asserted-by":"crossref","first-page":"771","DOI":"10.7326\/0003-4819-117-9-771","article-title":"Carcinoma of the male breast","volume":"117","author":"Jaiyesimi","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib160","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/1097-0142(19880801)62:3<474::AID-CNCR2820620305>3.0.CO;2-2","article-title":"Advanced male breast cancer treatment with the LH\u2013RH analogue buserelin alone or in combination with the antiandrogen flutamide","volume":"62","author":"Doberauer","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib161","first-page":"275","article-title":"Complete response to combination therapy with an LHRH agonist and flutamide in metastatic male breast cancer: a case report","volume":"13","author":"Labrie","year":"1990","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib162","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/1097-0142(19930715)72:2<502::AID-CNCR2820720228>3.0.CO;2-1","article-title":"Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer","volume":"72","author":"Lopez","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib163","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1200\/JCO.2006.07.2397","article-title":"Leuprolide acetate plus aromatase inhibition for male breast cancer","volume":"24","author":"Giordano","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib164","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/1097-0142(19810501)47:9<2185::AID-CNCR2820470913>3.0.CO;2-B","article-title":"Treatment of advanced male breast cancer","volume":"47","author":"Kraybill","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib165","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1200\/JCO.2005.04.173","article-title":"Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group","volume":"23","author":"Marty","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib166","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa052122","article-title":"Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer","volume":"353","author":"Romond","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib167","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","article-title":"Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2","volume":"344","author":"Slamon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib168","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(07)60028-2","article-title":"2-Year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial","volume":"369","author":"Smith","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib169","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ng0596-123","article-title":"BRCA2 germline mutations in male breast cancer cases and breast cancer families","volume":"13","author":"Couch","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib170","first-page":"313","article-title":"Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population","volume":"60","author":"Friedman","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib171","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/bjc.1997.574","article-title":"Germline BRCA2 mutations in men with breast cancer","volume":"76","author":"Mavraki","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib172","first-page":"1367","article-title":"BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease","volume":"58","author":"Haraldsson","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib173","first-page":"995","article-title":"High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history","volume":"59","author":"Csokay","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib174","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/(SICI)1098-2264(199901)24:1<56::AID-GCC8>3.0.CO;2-X","article-title":"Somatic genetic alterations in BRCA2-associated and sporadic male breast cancer","volume":"24","author":"Tirkkonen","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib175","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/10906570050501579","article-title":"Genetic analyses of male breast cancer in Israel","volume":"4","author":"Sverdlov","year":"2000","journal-title":"Genet Test"},{"key":"10.1016\/j.critrevonc.2009.04.003_bib176","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/1098-1004(2001)17:1<73::AID-HUMU12>3.0.CO;2-O","article-title":"BRCA2 germline mutations in male breast cancer patients in the Polish population","volume":"17","author":"Kwiatkowska","year":"2001","journal-title":"Hum Mutat"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084280900078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084280900078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T22:13:29Z","timestamp":1684966409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104084280900078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":176,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S104084280900078X"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2009.04.003","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}